Stock Earnings

Question 1

What are Virax Biolabs Group Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Virax Biolabs Group Ltd has a total asset of $6, Net loss of $-6

Question 2

What are the key financial ratios for VRAX?

Accepted Answer

Virax Biolabs Group Ltd's Current ratio is 0, has a Net margin is 0, sales per share of $0.

Question 3

How is Virax Biolabs Group Ltd's revenue broken down by segment or geography?

Accepted Answer

Virax Biolabs Group Ltd largest revenue segment is ViraxClear and ViraxVet, at a revenue of 156,419 in the most earnings release.For geography, United Kingdom, Hong Kong, Singapore, China, British Virgin Islands is the primary market for Virax Biolabs Group Ltd, at a revenue of 156,419.

Question 4

Is Virax Biolabs Group Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Virax Biolabs Group Ltd has a net loss of $-6

Question 5

Does Virax Biolabs Group Ltd have any liabilities?

Accepted Answer

no, Virax Biolabs Group Ltd has liability of 0

Question 6

How many outstanding shares for Virax Biolabs Group Ltd?

Accepted Answer

Virax Biolabs Group Ltd has a total outstanding shares of 4.34

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Selling, General & Admin	4	4	4	5	1	0
Research & Development	1	1	1	0	0	0
Operating Expenses	6	6	6	5	1	0
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-6	-6	-6	-5	-1	0
Income Tax Expense	0	0	--	--	--	--
Net Income	-6	-6	-6	-5	-1	0
Net Income Growth	0%	0%	20%	400%	--	--
Shares Outstanding (Diluted)	4.35	3.73	2	1.06	11.37	11.37
Shares Change (YoY)	95%	86%	89%	-91%	0%	0%
EPS (Diluted)	-1.39	-1.62	-3.35	-5.13	-0.15	-0.06
EPS Growth	-54%	-52%	-35%	3,322.99%	150%	0%
Free Cash Flow	-5	-5	-7	-4	0	0
Free Cash Flow Per Share	-1.14	-1.34	-3.48	-3.76	0	0
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-6	-6	-6	--	--	--
EBITDA Margin	0%	0%	0%	--	--	--
D&A For EBITDA	0	0	0	--	--	--
EBIT	-6	-6	-6	-5	-1	0
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	--	--	--	--

Virax Biolabs Group Ltd (VRAX) Price

VRAX Stock Price Chart

VRAX Income

Follow-Up Questions